Clinical trial NCT04819126: Nintendo Wii Virtual Reality Application In Dementia
Official title: Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Age-Related Memory Disorders
Keywords: Alzheimer's Dementia
Muscle strength
Fall
Virtual reality
Lead sponsor: Kırıkkale University
Sponsor class: OTHER
First posted: 2021-03-26
Enrollment: 32
Sex: ALL
Minimum age (years): 65
Maximum age (years): 80
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: •This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).

Detailed description: Purpose: This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

Method: The study included a total of 32 volunteers between the ages of 65-80, with mild or moderate AD diagnosed. These individuals were divided into 2 groups as a training group and control group. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes. Mini-Mental State Test, Knee Extension Muscle Strength, Timed Up and Go Test, Tinetti Falls Efficacy Scale results of individuals were recorded in the evaluation.

Eligibility criteria: Inclusion Criteria:

* included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,
* who did not have any difficulty or problems in communicating,
* who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,
* who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)

Exclusion Criteria:

* Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),
* Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,
* Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),
* Those with a lower or upper extremity amputation at any level

Primary outcomes:
measure: Age :mean or median age
timeFrame: period of 6 weeks
measure: Body Mass Index
timeFrame: period of 6 weeks
measure: Sex/Gender
timeFrame: period of 6 weeks
Secondary outcomes:
measure: The Mini-Mental State Test for Cognitive status
timeFrame: period of 6 weeks
Other outcomes:
Locations:
city: Konya
country: Turkey
facility: Karaman Ahmet Mete Nursing Home
Study officials:
affiliation: Karaman Ahmet Mete Nursing Home. Konya in Turkey
name: Konya Karaman Ahmet Mete Nursing Home
role: PRINCIPAL_INVESTIGATOR
References: